Skip to main content

Table 6 Survival rate and relative risk according to risk group as defined by the ICPS system

From: An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era

Risk group No.of patients (%) 3-year OS (%) RR (95%Cl) P-value 3-year PFS (%) RR (95%Cl) P-value
ICPS = 0 202(35.8) 95.6 1.000(N/A) <0.001 86.5 1.000(N/A) <0.001
ICPS = 1 144(25.5) 88.2 2.270(1.063–4.847) 0.034 82.3 1.409(0.838–2.369) 0.196
ICPS = 2 99(17.6) 76.0 4.395(2.118–9.118) <0.001 71.6 2.241(1.333–3.767) 0.002
ICPS = 3 119(21.1) 62.2 8.645(4.482–16.676) <0.001 54.5 3.957(2.518–6.216) <0.001
  1. Abbreviations: 3Y–OS 3-year overall survival, 3Y–PFS 3-year progression-free survival, RR Relative risk, 95% Cl, 95% confidence limits, ICPS Inflammation-based cumulative prognostic score
\